Navigation Links
Pitt-Stanford research suggests aimless proteins crucial to disease

PITTSBURGHResearchers from the University of Pittsburgh and Stanford University discovered that a supposedly inactive protein actually plays a crucial role in the ability of one the world's most prolific pathogens to cause disease, findings that suggest the possible role of similarly errant proteins in other diseases.

The team reports in the Proceedings of the National Academy of Sciences (PNAS) that Toxoplasma gondiithe parasitic protozoa behind toxoplasmosisattacks healthy cells by first injecting them with pseudokinases, which are enzymes that have abandoned their original function of transferring phosphates. When the researchers engineered strains of T. gondii without a particular pseudokinase gene cluster called ROP5, the pathogen was subsequently unable to cause disease in micea notable loss of potency in an organism that can infect nearly any warm-blooded animal.

These results are among the first to implicate pseudokinases as indispensible actors in pathogen-based disease, said senior author Jon Boyle, a professor in the Department of Biological Sciences in Pitt's School of Arts and Sciences. Boyle coauthored the paper with John Boothroyd, a professor of microbiology and immunology in the Stanford School of Medicine. Boyle and Boothroyd worked with Michael Reese, a postdoctoral researcher in Boothroyd's lab, as well as Gusti Zeiner and Jeroen Saeij, former postdoctoral researchers under Boothroyd.

The Pitt-Stanford project suggests that the significance of these aimless enzymes to T. gondii could apply to pseudokinases in other pathogens, Boyle said, including the parasite's close relative Plasmodium, which causes malaria.

"Our work shows that just because these proteins have lost their original function does not mean they don't do anything," Boyle said. "T. gondii cannot cause disease without them, and if one is trying to understand how pathogens work, the role of these proteins should obviously be considered."

The ROP5, or rhoptry protein 5, gene clusterso named for the specialized organelle rhoptry, which secretes thembelongs to a larger family of approximately 40 pseudokinases present in T. gondii. Once T. gondii injects ROP5 into the host cell, the parasite enters the cell and forms a protective membrane pocket, or vacuole, around itself to which ROP5 and other proteins attach. While the other secreted kinases are known to help disable or disrupt activity in the host cell, the ROP5 cluster, a kind of infectious ringleader, appeared to have a more dominant role in causing severe disease in mice than other virulence factors, Boyle said.

The team plans to further investigate the significance of ROP5 to T. gondii's survival within the host, Boyle said. In the PNAS paper, the researchers suggest that ROP5 has undergone multiple rounds of gene duplication followed by mutation of the individual copies. Thus, the authors propose, the ROP5 cluster may act like a genetic Swiss Army Knife, a multipurpose tool that allows T. gondii to adapt to and infect its famously wide variety of hosts.


Contact: Morgan Kelly
University of Pittsburgh

Related medicine news :

1. New strategic plan for NIH obesity research seeks to curb epidemic
2. Researchers need to engage lesbian, gay, bisexual, and transginder populations in health studies
3. Researchers publish molecular disease model for melanoma
4. Researchers find possible clues to tamoxifen resistance in breast cancer patients
5. UCSF researchers identify promising new treatment for childhood leukemia
6. Research explores link between asthma and smoking
7. Researchers make the leap to whole-cell simulations
8. UT Southwestern research advances fight against kidney cancer
9. Stepchildren relate to stepparents based on perceived benefits, researchers find
10. Researchers find many elderly men are undergoing unnecessary PSA screenings
11. LGBT health research gaps and needs: IOM report release March 31
Post Your Comments:
(Date:11/26/2015)... ... November 26, 2015 , ... Patients at Serenity Point ... come together on Thanksgiving Day to share the things that they are most ... Serenity Point YouTube channel, patients displayed what they wrote on index cards, describing ...
(Date:11/26/2015)... ON (PRWEB) , ... November 26, 2015 , ... ... of a real-time eReferral system for diagnostic imaging in the Waterloo region. Using ... BMD and Nuclear Medicine tests directly from their electronic medical record (EMR) without ...
(Date:11/26/2015)... ... 26, 2015 , ... The Catalent Applied Drug Delivery Institute ... integrate dose form selection in early phase drug development. The first of these ... bringing together the UK’s emerging life sciences companies, corporate partners, and investors, at ...
(Date:11/26/2015)... ... 2015 , ... PRMA Plastic Surgery is updating their record books yet again ... free flap breast reconstruction surgery! , “What an accomplishment for the PRMA team, says ... and it’s an honor to have served all of these women.” , PRMA is ...
(Date:11/26/2015)... Aliso Viejo, CA (PRWEB) , ... November 26, ... ... X users a new set of retro-fused, self-animating trailer titles with ProTrailer: Vintage. ... custom style options. These classically-influenced trailer titles work with any font, giving users ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... 2015 --> ... blends immunotherapy with Bremachlorin-photodynamic therapy for advanced cancer. ... immunotherapy with Bremachlorin-photodynamic therapy for advanced cancer.   ... immunotherapy with Bremachlorin-photodynamic therapy for advanced cancer.   ... that immunotherapy can be efficiently combined with photodynamic therapy ...
(Date:11/26/2015)... 26, 2015 --> ... SyMRI to find optimal contrast weighting of MRI for ... has signed a research agreement with SyntheticMR in order to ... SyMRI, it is possible to generate multiple contrast images from ... patient has left, thus making it possible to both fine ...
(Date:11/26/2015)... FRANCISCO , November 26, 2015 ... billion by 2022, according to a new report by Grand ... Chronic Kidney Disease (CKD) which demands kidney transplantation is expected ... and cost effective substitute for organ transplantation. --> ... billion by 2022, according to a new report by Grand ...
Breaking Medicine Technology: